Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1993-11-16
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0310-057X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
477-8
|
pubmed:dateRevised |
2006-8-28
|
pubmed:meshHeading |
pubmed-meshheading:8214562-Adolescent,
pubmed-meshheading:8214562-Disease Susceptibility,
pubmed-meshheading:8214562-Humans,
pubmed-meshheading:8214562-Male,
pubmed-meshheading:8214562-Malignant Hyperthermia,
pubmed-meshheading:8214562-Metoclopramide,
pubmed-meshheading:8214562-Neuroleptic Malignant Syndrome
|
pubmed:year |
1993
|
pubmed:articleTitle |
Neuroleptic malignant syndrome and malignant hyperthermia.
|
pubmed:publicationType |
Letter,
Comment,
Case Reports
|